PsyLabs
PrivateLast Round
Series A
Aug 15, 2025
Est. Valuation
$10M
Total Funding Raised
$9.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PsyLabs operates in Healthcare & Life Sciences and is based in Cape Town. Its latest recorded funding round was a Series A round in August 2025.
PsyLabs is a biotechnology company that specializes in the cultivation, extraction, and production of pharmaceutical-grade psychedelic active pharmaceutical ingredients (APIs) for medical and clinical research markets.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Mental Health, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PsyLabs Comparables
Compare PsyLabs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Natural MedTech | 89% | |
| Psygen Industries Ltd. | 83% | |
| Eywa Biotech | 81% |
For institutional investors. Book with your work email.
PsyLabs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 15, 2025 | ||||
| Strategic | Apr 15, 2025 | ||||
| Seed | Dec 3, 2024 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 15, 2026
Grew 25% QoQ, from 12 to 15 employees.
For institutional investors. Book with your work email.
PsyLabs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PsyLabs's valuation, stock price, and market status.
Is PsyLabs a public or private company?
PsyLabs is a private company.
What is the current stock price of PsyLabs?
PsyLabs is a private company, so its shares have no public market price. Caplight tracks PsyLabs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PsyLabs worth (valuation)?
PsyLabs's valuation is estimated at $10.0M based on funding round data.
Can I buy PsyLabs stock?
PsyLabs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PsyLabs's last funding round?
PsyLabs's most recent funding round was Series A on August 15, 2025.
Who are the main investors in PsyLabs?
Investor information for PsyLabs is not publicly disclosed.
Will PsyLabs IPO soon?
No public IPO plans have been announced for PsyLabs.
How can I track PsyLabs secondary market activity?
Caplight tracks bids, offers, and trades in PsyLabs's shares on secondary markets.